CA

CHI Advisors Portfolio holdings

AUM $252M
This Quarter Return
-4.45%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
10 Year Return
AUM
$261M
AUM Growth
+$261M
Cap. Flow
+$48.7M
Cap. Flow %
18.62%
Top 10 Hldgs %
82.88%
Holding
26
New
4
Increased
13
Reduced
1
Closed

Top Sells

1
ONCR
Oncorus, Inc.
ONCR
$63K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$47.2M 18.03% 1,671,976 +86,880 +5% +$2.45M
CGEM icon
2
Cullinan Oncology
CGEM
$445M
$39.1M 14.92% 3,047,609 +294,562 +11% +$3.78M
RPTX icon
3
Repare Therapeutics
RPTX
$71.7M
$37M 14.14% 2,646,781 +65,684 +3% +$919K
PLRX icon
4
Pliant Therapeutics
PLRX
$101M
$24.9M 9.5% 3,106,807 +449,350 +17% +$3.6M
VECT
5
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$20.4M 7.8% 3,782,199 +697,889 +23% +$3.77M
KZR icon
6
Kezar Life Sciences
KZR
$28.9M
$15.2M 5.81% 1,840,793 +1,526,181 +485% +$12.6M
TSVT
7
DELISTED
2seventy bio
TSVT
$10.8M 4.13% 819,672
INZY
8
DELISTED
Inozyme Pharma
INZY
$9.7M 3.71% 2,033,802 +1,141,745 +128% +$5.45M
CMPX icon
9
Compass Therapeutics
CMPX
$483M
$7.5M 2.86% 2,829,712
IMA
10
ImageneBio, Inc. Common Stock
IMA
$150M
$4.83M 1.85% 1,090,937 +276,182 +34% +$1.22M
DTIL icon
11
Precision BioSciences
DTIL
$57.8M
$4.81M 1.84% 3,003,751 +2,397,122 +395% +$3.84M
NKTX icon
12
Nkarta
NKTX
$151M
$4.41M 1.68% +358,013 New +$4.41M
FRLN
13
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$4.23M 1.62% 4,862,319
OMGA
14
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$4.01M 1.53% 1,055,882
AKUS
15
DELISTED
Akouos, Inc. Common Stock
AKUS
$3.92M 1.5% 836,120
GTHX
16
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$3.79M 1.45% 767,235 +278,600 +57% +$1.38M
ORTX
17
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.1M 1.18% 5,307,751
ONCR
18
DELISTED
Oncorus, Inc.
ONCR
$2.98M 1.14% 2,367,436 -50,000 -2% -$63K
LRMR icon
19
Larimar Therapeutics
LRMR
$310M
$2.97M 1.13% 1,515,148
KROS icon
20
Keros Therapeutics
KROS
$618M
$2.86M 1.09% 103,429 +41,200 +66% +$1.14M
CRVS icon
21
Corvus Pharmaceuticals
CRVS
$428M
$2.19M 0.84% 2,214,184 +511,047 +30% +$506K
TRDA icon
22
Entrada Therapeutics
TRDA
$208M
$1.99M 0.76% +163,496 New +$1.99M
OVID icon
23
Ovid Therapeutics
OVID
$91M
$1.86M 0.71% 864,822 +11,934 +1% +$25.7K
EIGR
24
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.2M 0.46% +190,000 New +$1.2M
PHAS
25
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$450K 0.17% +750,000 New +$450K